DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 16.20.
| Share Price | ₹6,293.6 | Feb 19,2026 |
| Market Cap | ₹167,095.1 Cr | |
| Sales-TTM | ₹10,314.0 Cr | TTM-Consolidated Results |
| Price/Sales | 16.20x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹167,095.1 Cr] as on Feb 19,2026
(/) Sales [ ₹10,314.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 16.20x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '16.20 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.89x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| DIVIS LABORATORIES | 10,314.0 | 16.20 | 167,095.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.24 | 411,054.0 |
| CIPLA LTD | 28,351.1 | 3.79 | 107,358.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.22 | 142,904.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.08 | 106,813.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.05 | 84,111.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.48 | 90,787.5 |
| LUPIN LTD | 26,150.5 | 3.89 | 101,848.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.06 | 68,287.8 |
| ABBOTT INDIA LTD | 6,824.1 | 8.22 | 56,075.7 |
| ALKEM LABORATORIES LTD | 14,252.7 | 4.51 | 64,259.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.06x |
| Max industry PS | 16.20x |
| Median industry PS | 4.51x |
| Average industry PS | 6.34x |
You may also like the below Video Courses